Explore more publications!

Technology Digest Yemen: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Yemen.

Press releases published on December 22, 2025

Sinaptica Therapeutics Completes Scientific Advisory Board, Bringing Together Leading Voices Across Patients, Science, Medicine, and Commercial Strategy
Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
Ascendiant Capital Markets: “Society Pass Inc (Nasdaq: SOPA) stock is undervalued and should be higher on NusaTrip valuation”
EagleNXT Appoints Falcon UAV as Master Distributor for Asia Pacific Region
Kahuna Labs Names Customer Support Visionary Judith Platz as Field Chief Customer Officer to Help Redefine the Future of Enterprise Support with AI
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Secura Bio Provides Corporate Update and Highlights Progress in its Phase 3 TERZO Study
Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
和誉医药CSF-1R抑制剂贝捷迈®获NMPA批准,填补中国腱鞘巨细胞瘤系统性治疗空白
Azureon Selects ServiceTitan as Core Technology Platform to Modernize Pool Construction and Service Operations to Scale End-to-End Management
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
Biosplice Therapeutics Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD Platinum‑Resistant Ovarian Cancer
BlackRock® Canada Announces Estimated December Cash Distributions for the iShares® ETFs
BlackRock® Canada Announces Estimated Annual Reinvested Capital Gains Distributions for the iShares® ETFs
Aurora Mobile’s EngageLab Powers Mission-Critical Communications for Ecuador’s National Electoral Council

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions